Abbott Laboratories
ABT
$132.81
$0.8050.61%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 7.28B | 6.84B | 7.97B | 7.79B | 7.22B |
| Total Receivables | 7.97B | 7.33B | 6.93B | 7.05B | 6.85B |
| Inventory | 6.95B | 6.64B | 6.19B | 6.81B | 6.81B |
| Prepaid Expenses | 2.15B | 2.16B | 2.18B | 2.05B | 2.02B |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 111.00M | 188.00M | 390.00M | 101.00M | 210.00M |
| Total Current Assets | 24.47B | 23.15B | 23.66B | 23.80B | 23.12B |
|
|
|||||
| Total Current Assets | 24.47B | 23.15B | 23.66B | 23.80B | 23.12B |
| Net Property, Plant & Equipment | 11.40B | 10.93B | 11.73B | 10.62B | 10.23B |
| Long-term Investments | 23.95B | 23.36B | 23.11B | 23.66B | 23.31B |
| Goodwill | 23.95B | 23.36B | 23.11B | 23.66B | 23.31B |
| Total Other Intangibles | 5.92B | 6.26B | 6.65B | 7.35B | 7.83B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 17.62B | 17.14B | 15.70B | 8.33B | 7.96B |
| Total Assets | 84.00B | 81.45B | 81.41B | 74.36B | 73.02B |
|
|
|||||
| Total Accounts Payable | 4.31B | 4.21B | 4.20B | 4.03B | 4.13B |
| Total Accrued Expenses | 6.81B | 6.56B | 6.59B | 6.77B | 6.39B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 507.00M | 506.00M | 1.75B | 2.17B | 1.63B |
| Total Finance Division Other Current Liabilities | 1.82B | 1.73B | 1.62B | 1.93B | 1.62B |
| Total Other Current Liabilities | 1.82B | 1.73B | 1.62B | 1.93B | 1.62B |
| Total Current Liabilities | 13.44B | 13.00B | 14.16B | 14.90B | 13.76B |
|
|
|||||
| Total Current Liabilities | 13.44B | 13.00B | 14.16B | 14.90B | 13.76B |
| Long-Term Debt | 12.96B | 12.78B | 12.63B | 12.88B | 13.21B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 896.00M | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.77B | 6.60B | 5.84B | 6.55B | 6.48B |
| Total Liabilities | 33.17B | 32.38B | 33.51B | 34.33B | 33.46B |
|
|
|||||
| Common Stock & APIC | 25.28B | 25.13B | 25.15B | 25.02B | 24.86B |
| Retained Earnings | 48.47B | 47.72B | 47.26B | 39.06B | 38.35B |
| Treasury Stock & Other | -23.19B | -24.03B | -24.75B | -24.28B | -23.89B |
| Total Common Equity | 50.57B | 48.81B | 47.66B | 39.80B | 39.32B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 50.57B | 48.81B | 47.66B | 39.80B | 39.32B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 264.00M | 253.00M | 237.00M | 232.00M | 242.00M |
| Total Equity | 50.83B | 49.06B | 47.90B | 40.03B | 39.56B |
|
|
|||||